PB2219: A REAL-WORLD EXPERIENCE WITH HEALTHCARE RESOURCE UTILIZATION PATTERNS AND RELATED COSTS IN PATIENTS WITH SICKLE CELL DISEASE IN NORTH LEBANON

• A. Inati,
• M. Sabbagh,
• C. Al Alam,
• A. Al Kheir,
• Z. Massouh,
• R. Demachkie,
• C. Ojaimy,
• N. Dani,
• A. Siddiqui,
• R. Rajat Adhikary,
• B. Lynch,
• A. Srivastava

Affiliations

A. Inati

1 School of Medicine, Lebanese American University

M. Sabbagh

2 Novartis, Beirut, Lebanon

C. Al Alam

3 American Center for Psychiatry and Neurology, Abu Dhabi, United Arab Emirates

A. Al Kheir

4 Saudi German Hospital, Dammam, Saudi Arabia

Z. Massouh

5 Department of Pediatrics, NINI Hospital, Tripoli

R. Demachkie

6 School of Medicine, Lebanese American University, Byblos, Lebanon

C. Ojaimy

5 Department of Pediatrics, NINI Hospital, Tripoli

N. Dani

7 Novartis

A. Siddiqui

8 Novartis Pharma AG, Basel, Switzerland

R. Rajat Adhikary

9 Novartis, Hyderabad, India

B. Lynch

10 Novartis, Dublin, Ireland

A. Srivastava

9 Novartis, Hyderabad, India